Injeq Oy Shares Have Been Transferred to Finnish Book-Entry Securities System – Instructions for Shareholders

Injeq Oy Annual General Meeting resolved on 26th May 2021 to transfer the shares of the company into the Finnish book-entry securities system. Appropriate instructions were sent to all shareholders by email in June 2021 and on 16th September 2021 the shares were incorporated in the book-entry system. In case you have not received the said instructions, or your shares have not been transferred for some other reason, we ask you to contact ir@injeq.com for instructions.

The transfer to the Finnish book-entry securities system means that the maintenance of the Company’s shareholder register has been transferred to Euroclear Finland Ltd. A shareholder may not use shareholder rights in the Company before the shareholder has been registered in the shareholders’ register maintained in Euroclear Finland Ltd. The shareholding of each shareholder will be entered into the shareholder’s personal book-entry account in connection with the transfer to the Finnish book-entry securities system.

If your place of residence is outside Finland and your foreign bank can’t take into custody unlisted Finnish securities, and you are unwilling or unable to open a book-entry account in Finland, you do not need to do anything at this point – your ownership will remain unchanged. If the Company’s securities are listed in the future, this should allow your bank to then take custody of your newly listed securities.

For any questions or to update your contact information for future use please do not hesitate to contact us at ir@injeq.com.

Board of Directors of Injeq Oy

Injeq participating SIOP 2022 in Barcelona 28th September -1st October

Injeq is very excited to attend the SIOP Congress to present our amazing IQ-Tip system to doctors, patients and their […]
Read more »

Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971–2008 in Denmark, Finland, and Sweden: A population-based cohort study

An interesting article from Sørensen et al. about long term survival from childhood ALL (acute lymphoblastic leukemia). According to this […]
Read more »

German reseller Florian Holderer was dazzled by the smart needle

Ecumed’s CEO Florian Holderer emphasizes the importance of user experience and trust in the marketing of the IQ-Tip®​ smart needle. Florian Holderer […]
Read more »

Changes to the Injeq Plc. Board

The Annual General Meeting held on May 31 2022 made the regular decisions as defined in the by-laws. The new […]
Read more »

Incidence of traumatic lumbar punctures in neonates and infants

The part two of the trilogy has now been published. This article of the three part series examines the incidence […]
Read more »

Injeq whitepaper on lumbar puncture

Our whitepaper takes a closer look at the lumbar puncture, the IQ-Tip® system’s first indication, and presents the results that […]
Read more »